Medication

FILE- This Nov. 14, 2018, file photo shows Lubriderm, a Johnson & Johnson product, on display at a market in Pittsburgh. Johnson & Johnson reports financial results Tuesday, Oct. 14, 2019. (AP Photo/Gene J. Puskar, File)
October 15, 2019 - 8:37 am
NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson's third-quarter profit jumped 23%, beating Wall Street forecasts, thanks to higher sales of its key medicines for cancer and immune disorders and an acquisition-related charge a year earlier. The world's biggest maker of health care products also...
Read More
FILE - This Aug. 29, 2018, file photo shows an arrangement of prescription oxycodone pills in New York. U.S. health officials are again warning doctors against abandoning chronic pain patients by abruptly stopping their opioid prescriptions. The U.S. Department of Health and Human Services instead urged doctors Thursday, Oct. 10, 2019, to share such decisions with patients. (AP Photo/Mark Lennihan, File)
October 10, 2019 - 12:19 pm
U.S. health officials again warned doctors Thursday against abandoning chronic pain patients by abruptly stopping their opioid prescriptions. The U.S. Department of Health and Human Services instead urged doctors to share such decisions with patients. The agency published steps for doctors in a six...
Read More
FILE - In this July 30, 2013, file photo, people walk along a corridor at the headquarters of Johnson & Johnson in New Brunswick, N.J. A Philadelphia jury has ruled that Johnson & Johnson and Janssen Pharmaceuticals must pay $8 billion in punitive damages over an antipsychotic drug linked to the abnormal growth of female breast tissue in boys. A law firm for the plaintiff released a statement Tuesday, Oct. 8, 2019, saying the companies used an organized scheme to make billions of dollars while illegally marketing and promoting the drug called Risperdal. (AP Photo/Mel Evans, File)
October 08, 2019 - 8:27 pm
PHILADELPHIA (AP) — A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff's attorneys say is linked to the abnormal growth of female breast tissue in boys. Johnson and Johnson...
Read More
Professor Gregg Semenza, accompanied by Johns Hopkins University President Ron Daniels, waves to the crowd during a news conference after he was awarded the 2019 Nobel Prize in Medicine at Johns Hopkins Medicine Hospital in Baltimore, Md., Monday, Oct. 7, 2019. The 2019 Nobel Prize in Medicine has been jointly awarded to William Kaelin Jr., Sir Peter Ratcliffe and Gregg Semenza for their pioneering research into how human cells respond to changing oxygen levels. (AP Photo/Jose Luis Magana)
Associated Press
October 07, 2019 - 8:35 pm
NEW YORK (AP) — Two Americans and a British scientist won a Nobel Prize on Monday for discovering details of how the body's cells sense and react to low oxygen levels, providing a foothold for developing new treatments for anemia, cancer and other diseases. Drs. William G. Kaelin Jr. of Harvard...
Read More
This undated photo provided by Johns Hopkins University shows Gregg L. Semenza at the university in Baltimore. Semenza, a Johns Hopkins University researcher, was awarded the Nobel Prize for Physiology or Medicine on Monday, Oct. 7, 2019. He will share the prize with Drs. William G. Kaelin Jr. and Peter J. Ratcliffe for their discoveries of how cells sense and adapt to oxygen availability, the Nobel Committee announced Monday. (Johns Hopkins University via AP)
October 07, 2019 - 8:48 am
STOCKHOLM (AP) — The Latest on the Nobel Prize in Medicine or Physiology (all times local): 2:40 p.m. Dr. Gregg Semenza, a top researcher at Johns Hopkins University in Baltimore, says he was awakened by a call from Stockholm shortly before 4 a.m. with the good news that he is one of three...
Read More
October 03, 2019 - 5:26 pm
WHITE PLAINS, N.Y. (AP) — OxyContin maker Purdue Pharma should be prohibited from giving $38 million in employee payouts as it goes through bankruptcy, attorneys general from 24 states said in a court filing Thursday. Purdue has said it needs to make bonus payments to keep employees and maintain...
Read More
FILE - In this July 30, 2013, file photo, large banners hang in an atrium at the headquarters of Johnson & Johnson in New Brunswick, N.J. Johnson & Johnson has become the latest company to settle a lawsuit to get out of the first federal trial over the nation's opioids crisis, reaching a deal worth more than $20 million with two Ohio counties, the company announced Tuesday, Oct. 1, 2019. (AP Photo/Mel Evans, File)
October 01, 2019 - 9:28 pm
Johnson & Johnson on Tuesday announced it had reached an agreement worth more than $20 million with two Ohio counties, becoming the latest company to settle a lawsuit to get out of the first federal trial over the nation's opioids crisis. The deal with Cuyahoga and Summit counties comes a...
Read More
This undated photo provided by the Southwest Virginia Regional Jail Authority shows Dr. Joel Smithers. Smithers is facing the possibility of life in prison after being convicted in May of more than 800 counts of illegally prescribing drugs, including oxycodone and oxymorphone that caused the death of a West Virginia woman. When he is sentenced Wednesday, Oct. 2, 2019 the best Smithers can hope for is a mandatory minimum of 20 years.Southwest Virginia Regional Jail Authority) .
WCBS 880 Newsroom
September 28, 2019 - 9:37 am
RICHMOND, Va. (AP) — By the time drug enforcement agents swooped into his small medical office in Martinsville, Virginia, in 2017, Dr. Joel Smithers had prescribed about a half a million doses of highly addictive opioids in two years. Patients from five states drove hundreds of miles to see him,...
Read More
FILE - In this Tuesday, Sept. 17, 2019 file photo, an employee of Eurotunnel and his dog check trucks on their way to Britain during a day of test in case of no deal Brexit, at the exit of the Channel tunnel in Calais, northern France. Britain’s government watchdog says there is still a “significant amount” of work to do to ensure Britain has an adequate medicines supply in case of a no-deal Brexit. In a report issued on Friday, Sept. 27, the National Audit Office said additional shipping capacity chartered by the U.K. for sending goods across the English channel might not be operational until the end of November - one month after the Oct. 31 deadline. (Denis Charlet, Pool via AP, file)
September 27, 2019 - 5:32 am
LONDON (AP) — Britain's government watchdog says there is still a "significant amount" of work to do to make sure the country has an adequate supply of licensed drugs in case of a no-deal Brexit. In a report issued Friday, Britain's National Audit Office said additional shipping capacity chartered...
Read More
In this photo taken Sept. 20, 2019, David Alport, owner of the Bridge City Collective marijuana dispensary in Portland, Ore., goes over sales numbers with the store's general manager Cameron Moore. The company has seen a 31% decrease in its sales of vaping products in the past two weeks. “It’s having an impact on how consumers are behaving,” said Alport. “People are concerned, and we’re concerned.” (AP Photo/Gillian Flaccus)
September 26, 2019 - 8:55 pm
PORTLAND, Ore. (AP) — Vaping products, one of the fastest-growing segments of the legal marijuana industry, have taken a hit from consumers as public health experts scramble to determine what's causing a mysterious and sometimes fatal lung disease among people who use e-cigarettes. The ailment has...
Read More

Pages